Financials

  • Market Capitalization 4.37 B
  • Employee 798
  • Founded 1993
  • CEO Catherine Owen Adams
  • Website www.acadia.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHG9K0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
10.07
Relación precio/flujo de caja
3.46

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1424
EWTX
Edgewise Therapeutics, Inc. - Common Stock
41.27 USD-9.12%+1.90%+16.45%+170.98%4.44 B USD
1425
VKTX
Viking Therapeutics, Inc. - Common Stock
38.12 USD-1.90%-2.48%+30.82%+20.06%4.43 B USD
1463
DNLI
Denali Therapeutics Inc. - Common Stock
26.48 USD+3.12%+2.12%+21.13%+63.76%4.20 B USD
1478
TNGX
Tango Therapeutics, Inc. - Common Stock
28.36 USD-8.69%-6.43%-9.48%+358.16%4.10 B USD

ACADIA Pharmaceuticals Inc. - Common Stock

Acadia Pharmaceuticals Inc. es una empresa biofarmacéutica con sede en Del Mar, California.

Noticias